111C Rappaport, Elizabeth - Thomas Jefferson University - Thomas Jefferson University
Elizabeth B. Rappaport, MD

Elizabeth B. Rappaport, MD

Contact Dr. Rappaport

1015 Walnut Steet
Suite 401
Philadelphia, PA 19107

(215) 817-0029
(215) 955-0640 fax

Most Recent Peer-reviewed Publications

  1. Using routinely collected growth data to assess a school-based obesity prevention strategy
  2. Obesity and other predictors of absenteeism in philadelphia school children
  3. Identifying and evaluating the metabolic syndrome in children and adolescents
  4. Obesity, insulin resistance, and type 2 diabetes in children and adolescents
  5. The relationship of body mass index and blood pressure in primary care pediatric patients
  6. Overweight in Southeastern Pennsylvania children: 2002 Household health survey data
  7. Erratum: Rosiglitazone monotherapy is effective in patients with type 2 diabetes (Journal of Clinical Endocrinology and Metabolism 86 (280-288))
  8. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
  9. Rosiglitazone monotherapy is effective in patients wi 05B4 th type 2 diabetes
  10. Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes
  11. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: A twelve-week, randomized, placebo-controlled study
  12. Steroid 5α-reductase inhibitor treatment for benign prostatic hyperplasia
  13. Isotretinoin embryopathy - A continuing problem
  14. Effects of exogenous growth hormone on growth plate cartilage in rats
  15. Iatrogenic Creutzfeldt-Jakob disease
  16. Pituitary growth hormone from human cadavers: Neurologic disease in ten recipients
  17. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: Epidemiologic and pathogenetic implications
  18. Slipped capital femoral epiphysis in growth hormone-deficient patients
  19. Prevalence of salt-losing among congenital adrenal hyperplasia patients
  20. Altered erythrocyte Na+ + K+ pump in adolescent obesity
0